Forxiga ( DrugBank: - )

2 diseases

ID	Disease name (Link within this page)	Number of trials
86	Pulmonary arterial hypertension	1
88	Chronic thromboembolic pulmonary hypertension	1

86. Pulmonary arterial hypertension

Clinical trials : 1,205 / Drugs : 684 - (DrugBank : 124) / Drug target genes : 100 - Drug target pathways : 193

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-006787-25-DK (EUCTR)	06/07/2022	22/12/2021	The effects of dapagliflozin in patients with elevated blood pressure in the lungs	Effects of DAPAgliflozin on cardiopulmonary exercise capacity and hemodynamics in Pulmonary Arterial ...	Pulmonary arterial hypertensionChronic thromboembolic pulmonary hypertension MedDRA version: 21.1;Le ...	Trade Name: Forxiga (dapagliflozin) Product Name: Forxiga INN or Proposed INN: Dapagliflozin	Rigshospitalet The Heart Center	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	52	Phase 2	Denmark

Clinical trials : 157 / Drugs : 107 - (DrugBank : 22) / Drug target genes : 14 - Drug target pathways : 54

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-006787-25-DK (EUCTR)	06/07/2022	22/12/2021	The effects of dapagliflozin in patients with elevated blood pressure in the lungs	Effects of DAPAgliflozin on cardiopulmonary exercise capacity and hemodynamics in Pulmonary Arterial ...	Pulmonary arterial hypertensionChronic thromboembolic pulmonary hypertension MedDRA version: 21.1;Le ...	Trade Name: Forxiga (dapagliflozin) Product Name: Forxiga INN or Proposed INN: Dapagliflozin	Rigshospitalet The Heart Center	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	52	Phase 2	Denmark